Home/Filings/4/0001415889-23-004271
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-004271

CIK 0001583107other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:32 PM ET

Size

4.5 KB

Accession

0001415889-23-004271

Insider Transaction Report

Form 4
Period: 2023-03-01
GRAHAM RICHARD A
SVP, Development
Transactions
  • Award

    Ordinary Shares

    2023-03-01+75,000376,463 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:32 PM ET
Size
4.5 KB